Viewing Study NCT05568095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-01-31 @ 8:55 AM
Study NCT ID: NCT05568095
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-23
First Post: 2022-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
Sponsor: Arcus Biosciences, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Upper Gastrointestinal Tract Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Domvanalimab View
None Zimberelimab View
None Nivolumab View
None Advanced upper gastrointestinal tract adenocarcinoma View
None Gastroesophageal junction cancer View
None Esophageal adenocarcinoma View
None Gastric cancer View
None Gastric adenocarcinoma View